9.5
院前抗纤维蛋白剂,用于创伤性凝血病和出血
PATCH试验是一项多中心随机,双盲的,安慰剂对照的试验,对院前治疗tranexamic Acid治疗,针对严重受伤的患者,患有急性创伤性凝血病风险。 PATCH试验由国家卫生与医学研究委员会(NHMRC)资助。
https://clinicaltrials.gov/ct2/show/nct02187120
October 15, 2025
October 14, 2025
October 14, 2025
October 14, 2025
October 14, 2025
October 14, 2025
October 13, 2025
October 13, 2025
October 13, 2025
October 13, 2025
October 13, 2025
October 13, 2025